Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Debora Basilio Basilio-Queiros, MSc, Susanne Luther, Arnold Ganser, MD, Eva M Weissinger, MD

Blood (2019) 134 (Supplement_1): 1939.

https://doi.org/10.1182/blood-2019-121914

Published: 2019

Journal Articles

Urine Proteomic Analysis Reveals Disease-Specific Patterns in Pediatric Patients with Classical Hodgkin's Disease(HD). an Addon Study to the Euronet-PHL-C2 Trial

Blood (2019) 134 (Supplement_1): 2804.

https://doi.org/10.1182/blood-2019-125611

Published: 2019

Journal Articles

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Debora Queiros, MSc, Susanne Luther-Wolf, Eva M Weissinger, MD, Arnold Ganser, MD

Blood (2018) 132 (Supplement 1): 3327.

https://doi.org/10.1182/blood-2018-99-110779

Published: 2018

Journal Articles

The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD

Blood (2017) 130 (Supplement 1): 512.

https://doi.org/10.1182/blood.V130.Suppl_1.512.512

Published: 2017

Journal Articles

Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation

Christiane E Dobbelstein, MD, Elke Dammann, Eva M Weissinger, MD, Michael Stadler, MD, Matthias Eder, MD, Brigitte Schlegelberger, MD, PhD, Arnold Ganser, MD, Gudrun Gohring, MD

Blood (2013) 122 (21): 3362.

https://doi.org/10.1182/blood.V122.21.3362.3362

Published: 2013

Journal Articles

Graft Versus Leukemia With Little Graft Versus Host Disease? Long Term Follow-Up Of a Study Using Transduced Donor T-Cells For Donor Leukocyte Transfusion

Eva M Weissinger, MD, Sylvia Borchers, PhD, Justyna Ogonek, MSc, Kriti Verma, MSc, Steve Ehrlich, MD, Christian Koenecke, MD, Patrick Schweier, Chiara Bonini, MD, Fabio Ciceri, Elke Dammann, Susanne Luther, Jürgen Krauter, Prof. Dr. med., Michael Stadler, MD, Arnold Ganser

Blood (2013) 122 (21): 4207.

https://doi.org/10.1182/blood.V122.21.4207.4207

Published: 2013

Journal Articles

Prognostic Value Of Plasma Biomarkers Compared To Urinary Proteome Patterns

Christin Human, Sylvia Borchers, PhD, Michael Stadler, MD, Helmut Diedrich, Jürgen Krauter, MD, PhD, Christine Falk, Arnold Ganser, Eva M Weissinger, MD

Blood (2013) 122 (21): 4593.

https://doi.org/10.1182/blood.V122.21.4593.4593

Published: 2013

Journal Articles

Persistence of Recipient-Derived Antiviral T cells Severely Influence Donor Chimerism Post Allogeneic HSCT,

Sylvia Borchers, PhD, Michael Stadler, MD, Susanne Luther, Tina Ganzenmueller, Brigitte Pabst, Stefanie Buchholz, MD, Elke Dammann, Arnold Ganser, MD, Eva M Weissinger, MD

Blood (2011) 118 (21): 3240.

https://doi.org/10.1182/blood.V118.21.3240.3240

Published: 2011

Journal Articles

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Eva M. Weissinger, MD, Daniel Wolff, Jochen Metzger, Christiane E Dobbelstein, MD, Stefanie Buchholz, MD, Elke Dammann, Uwe Borchert, Annika Krons, Helmut Diedrich, Michael Stadler, MD, Anne M Dickinson, PhD, Ernst Holler, M.D., Hildegard T. Greinix, MD, Juergen Krauter, MD, Arnold Ganser, MD

Blood (2011) 118 (21): 1970.

https://doi.org/10.1182/blood.V118.21.1970.1970

Published: 2011

Journal Articles

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Tobias Feuchtinger, Kathrin Opherk, Wolfgang A. Bethge, Max S. Topp, Friedhelm R. Schuster, Eva M. Weissinger, Mohamad Mohty, Reuven Or, Michael Maschan, Michael Schumm, Klaus Hamprecht, Rupert Handgretinger, Peter Lang, Hermann Einsele

Blood (2010) 116 (20): 4360–4367.

https://doi.org/10.1182/blood-2010-01-262089

Published: 2010

Journal Articles

Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Eva M. Weissinger, Eric Schiffer, Bernd Hertenstein, James L. Ferrara, Ernst Holler, Michael Stadler, Hans-Jochem Kolb, Axel Zander, Petra Zürbig, Markus Kellmann, Arnold Ganser

Blood (2007) 109 (12): 5511–5519.

https://doi.org/10.1182/blood-2007-01-069757

Published: 2007

Includes: Supplemental data

Journal Articles

Isolation of Cytomegalovirus (CMV) Specific T-Cells from Sersopositve Donors: A Possible Tool for CMV-Prophylaxis.

Sylvia Borchers, Max Topp, Arnold Ganser, Hermann Einsele, Eva M. Weissinger, Bernd Hertenstein

Blood (2005) 106 (11): 3037.

https://doi.org/10.1182/blood.V106.11.3037.3037

Published: 2005

Journal Articles

Prospective Evaluation of Graft-Versus-Host Disease-Specific Proteomics Pattern in Patients after Allogeneic Stem Cell Transplantation.

Eva M. Weissinger, MD, Meike Hillmann, Hans-Jochem Kolb, MD, Axel R. Zander, MD, Ernst Holler, MD, Harald Mischak, PhD, Arnold Ganser, MD, Bernd Hertenstein, MD

Blood (2005) 106 (11): 3093.

https://doi.org/10.1182/blood.V106.11.3093.3093

Published: 2005

Journal Articles

Atypical Presentations of EBV Reactivation and EBV-Associated PTLD Post-HSCT: Implication for Routine EBV Surveillance after Allogeneic HSCT?.

Christiane E. Dobbelstein, MD, Haytham M. Kamal, MD, Elke Dammann, Bernd Hertenstein, MD, PhD, Eva M. Weissinger, MD, PhD, Arnold Ganser, MD, PhD.

Blood (2005) 106 (11): 5364.

https://doi.org/10.1182/blood.V106.11.5364.5364

Published: 2005

Journal Articles

Prospective Evaluation of a GvHD-Specific Proteom Pattern.

Eva M. Weissinger, MD, Thorsten Kaiser, Haytham Kamal, Hans-Jochem Kolb, MD, Ernst Holler, MD, Arnold Ganser, MD, Bernd Hertenstein, MD

Blood (2004) 104 (11): 728.

https://doi.org/10.1182/blood.V104.11.728.728

Published: 2004

NARROW

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Urine Proteomic Analysis Reveals Disease-Specific Patterns in Pediatric Patients with Classical Hodgkin's Disease(HD). an Addon Study to the Euronet-PHL-C2 Trial

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD

Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation

Graft Versus Leukemia With Little Graft Versus Host Disease? Long Term Follow-Up Of a Study Using Transduced Donor T-Cells For Donor Leukocyte Transfusion

Prognostic Value Of Plasma Biomarkers Compared To Urinary Proteome Patterns

Persistence of Recipient-Derived Antiviral T cells Severely Influence Donor Chimerism Post Allogeneic HSCT,

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Isolation of Cytomegalovirus (CMV) Specific T-Cells from Sersopositve Donors: A Possible Tool for CMV-Prophylaxis.

Prospective Evaluation of Graft-Versus-Host Disease-Specific Proteomics Pattern in Patients after Allogeneic Stem Cell Transplantation.

Atypical Presentations of EBV Reactivation and EBV-Associated PTLD Post-HSCT: Implication for Routine EBV Surveillance after Allogeneic HSCT?.

Prospective Evaluation of a GvHD-Specific Proteom Pattern.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only